Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Wound healing modulation in glaucoma surgery].

A Labbé1, C Khammari, C Baudouin

  • 1Service d'Ophtalmologie III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France. antoinelabbe@hotmail.com

Journal Francais D'Ophtalmologie
|July 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cataract surgery in eyes with nanophthalmos: Operative technique and refractive outcomes - A case series.

Journal francais d'ophtalmologie·2026
Same author

[Trabecular surgeries in the management of glaucoma: A review of literature].

Journal francais d'ophtalmologie·2026
Same author

Hemorrhagic serous choroidal detachment following micropulse transscleral cyclophotocoagulation in refractory glaucoma.

Journal francais d'ophtalmologie·2026
Same author

Real-life outcomes of the PAUL® Glaucoma Implant with ripcord in refractory glaucoma.

Journal francais d'ophtalmologie·2026
Same author

In vivo Doppler holography of the optic nerve head in glaucoma: Response to acute IOP decrease.

Journal francais d'ophtalmologie·2026
Same author

Secondary angle-closure by pupillary block in a pseudophakic vitrectomized patient.

Journal francais d'ophtalmologie·2025
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
Same journal

Granulomatous reaction after hybrid hyaluronic acid-calcium hydroxyapatite filler injection in supratarsal hollow correction.

Journal francais d'ophtalmologie·2026
Same journal

Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

Journal francais d'ophtalmologie·2026
See all related articles

Antifibrotic agents like 5-fluorouracil (5-FU) and mitomycin C (MMC) improve filtering surgery success but carry risks. Careful patient evaluation and tailored treatment selection are crucial to balance benefits and complications.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Wound Healing Research

Background:

  • Filtering surgery success heavily relies on the wound healing response.
  • Antifibrotic agents, 5-fluorouracil (5-FU) and mitomycin C (MMC), have significantly improved surgical outcomes, especially for high-risk patients.
  • However, these agents are linked to severe complications.

Purpose of the Study:

  • To evaluate the use of antifibrotic agents in filtering surgery.
  • To understand the relationship between patient risk factors for scarring and treatment efficacy.
  • To guide the optimal selection and application of antifibrotic agents.

Main Methods:

  • Review of antifibrotic agents (5-FU, MMC) in filtering surgery.
  • Analysis of patient risk factors influencing wound healing and scarring.

Related Experiment Videos

  • Evaluation of complication rates associated with antifibrotic agents.

    • Main Results:

    • 5-FU and MMC have modified the prognosis of filtering surgery.
    • These agents are associated with significant complications.
    • Careful consideration of patient-specific risk factors is necessary.

    Conclusions:

    • Maximizing benefits and minimizing complications requires careful evaluation of antifibrotic treatments.
    • The choice of agent, dose, and duration must be individualized.
    • Exhaustive preoperative assessment is essential for optimal patient management.